Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M16,174Revenue $M7,143Net Margin (%)3.3Z-Score0.9
Enterprise Value $M20,035EPS $-0.1Operating Margin %4.9F-Score8
P/E(ttm))43.5Cash Flow Per Share $1.5Pre-tax Margin (%)0.8Higher ROA y-yY
Price/Book2.510-y EBITDA Growth Rate %0Quick Ratio1.3Cash flow > EarningsY
Price/Sales2.35-y EBITDA Growth Rate %0Current Ratio1.8Lower Leverage y-yN
Price/Cash Flow3.8y-y EBITDA Growth Rate %1,029ROA % (ttm)1.4Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)3.7Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M1,323ROI % (ttm)-9.4Gross Margin Increase y-yY

Gurus Latest Trades with BSX

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BSXVanguard Health Care Fund 2014-06-30 Add0.2%$12.58 - $13.77
($13.01)
$ 12.33-5%Add 16.19%42,743,200
BSXRay Dalio 2014-06-30 Sold Out $12.58 - $13.77
($13.01)
$ 12.33-5%Sold Out0
BSXLeon Cooperman 2014-06-30 Reduce-0.35%$12.58 - $13.77
($13.01)
$ 12.33-5%Reduce -23.25%6,549,479
BSXRay Dalio 2014-03-31 Reduce-0.01%$11.91 - $13.98
($13.08)
$ 12.33-6%Reduce -70.15%36,884
BSXMichael Price 2013-12-31 Add0.47%$11.18 - $12.38
($11.81)
$ 12.334%Add 17.65%2,000,000
BSXRay Dalio 2013-12-31 Buy 0.01%$11.18 - $12.38
($11.81)
$ 12.334%New holding, 123584 sh.123,584
BSXLeon Cooperman 2013-12-31 Reduce-0.88%$11.18 - $12.38
($11.81)
$ 12.334%Reduce -36.64%8,533,099
BSXDodge & Cox 2013-12-31 Reduce-0.18%$11.18 - $12.38
($11.81)
$ 12.334%Reduce -22.34%45,938,468
BSXJoel Greenblatt 2013-12-31 Sold Out -0.01%$11.18 - $12.38
($11.81)
$ 12.334%Sold Out0
BSXLeon Cooperman 2013-09-30 Reduce-0.42%$9.15 - $11.99
($10.83)
$ 12.3314%Reduce -18.19%13,467,416
BSXDodge & Cox 2013-09-30 Reduce-0.25%$9.15 - $11.99
($10.83)
$ 12.3314%Reduce -27.68%59,157,107
BSXVanguard Health Care Fund 2013-09-30 Reduce-0.24%$9.15 - $11.99
($10.83)
$ 12.3314%Reduce -15.74%38,240,700
BSXCharles Brandes 2013-09-30 Sold Out -0.07%$9.15 - $11.99
($10.83)
$ 12.3314%Sold Out0
BSXJoel Greenblatt 2013-09-30 Reduce-0.02%$9.15 - $11.99
($10.83)
$ 12.3314%Reduce -69.22%18,744
BSXCharles Brandes 2013-06-30 Reduce-1.54%$7.09 - $9.64
($8.48)
$ 12.3345%Reduce -96.31%624,088
BSXDodge & Cox 2013-06-30 Reduce-0.14%$7.09 - $9.64
($8.48)
$ 12.3345%Reduce -14.79%81,801,130
BSXJoel Greenblatt 2013-06-30 Reduce-0.03%$7.09 - $9.64
($8.48)
$ 12.3345%Reduce -51.28%60,894
BSXLeon Cooperman 2013-03-31 Add0.24%$5.73 - $7.81
($7.12)
$ 12.3373%Add 13.43%16,473,300
BSXJoel Greenblatt 2013-03-31 Reduce-0.01%$5.73 - $7.81
($7.12)
$ 12.3373%Reduce -20.11%124,980
BSXRay Dalio 2013-03-31 Sold Out -0.0025%$5.73 - $7.81
($7.12)
$ 12.3373%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BSX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BSX Vanguard Health Care Fund 2014-06-3042,743,2003.231.4+16.19%
BSX Michael Price 2014-06-302,000,0000.153.1
BSX Dodge & Cox 2014-06-3044,872,8183.390.55-0.78%
BSX PRIMECAP Management 2014-06-3048,452,0193.660.68-1.82%
BSX Mario Gabelli 2014-06-301,785,8360.140.12-14.92%
BSX Leon Cooperman 2014-06-306,549,4790.51.1-23.25%
BSX Ray Dalio 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


BSX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MARIO ERNESTDirector 2014-09-02Sell10,000$12.6-2.14view
Phalen Michael P.EVP & President, MedSurg 2014-08-15Sell11,471$12.58-1.99view
MARIO ERNESTDirector 2014-08-01Sell10,000$12.58-1.99view
Pierce David ASVP and President, Endoscopy 2014-07-30Sell157$12.97-4.93view
Phalen Michael P.EVP & President, MedSurg 2014-07-15Sell67,500$13.04-5.44view
MARIO ERNESTDirector 2014-07-01Sell10,000$12.95-4.79view
Phalen Michael P.EVP & President, MedSurg 2014-06-16Sell13,500$13.02-5.3view
MARIO ERNESTDirector 2014-06-02Sell10,000$12.88-4.27view
Phalen Michael P.EVP & President, MedSurg 2014-05-15Sell13,500$12.76-3.37view
MARIO ERNESTDirector 2014-05-01Sell10,000$12.58-1.99view

Press Releases about BSX :

    Quarterly/Annual Reports about BSX:

    News about BSX:

    Articles On GuruFocus.com
    Diamond Hill Capital Comments on Boston Scientific Corp Jul 25 2014 
    Diamond Hill Capital Comments on Boston Scientific Corp Jun 26 2014 
    Diamond Hill Select Fund Commentary – First Quarter 2014 Jun 25 2014 
    Diamond Hill Capital Comments on Boston Scientific Corp Jan 15 2014 
    Vanguard Health Care Fund Selling Update Oct 30 2013 
    Diamond Hill Funds Q3 Market Review and Large-Cap Fund Commentary Oct 29 2013 
    Weekly CFO Sells Highlight: BSX, RKUS, MCRL, LRAD and SWKS Sep 08 2013 
    Charles Brandes Top Second Quarter Portfolio Changes Aug 09 2013 
    comment on BSX May 22 2013 
    BSX and ABMD Highlight Increased Insider Buying in the Medical Technology Sector May 14 2013 


    More From Other Websites
    CE Mark for Boston Scientific's Vercise in Essential Tremor Sep 17 2014
    Boston Scientific Receives CE Mark For The Vercise™ Deep Brain Stimulation (DBS) System For... Sep 16 2014
    REPRISE II Data Demonstrate Sustained Safety And Performance Outcomes At One Year For The Boston... Sep 15 2014
    Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014 Sep 10 2014
    Boston Scientific ordered to pay $73 million over mesh device Sep 09 2014
    Boston Scientific Ordered to Pay $73 Million Over Implant Sep 09 2014
    Insider Trading Alert - NNN, WDAY And BSX Traded By Insiders Sep 04 2014
    BostonScientific Posts NECTAR-HF Trial Data, Shares Drop Sep 03 2014
    Boston Scientific To Participate In 2014 Bank Of America Merrill Lynch Global Healthcare Conference Sep 03 2014
    Boston Scientific WallFlex Biliary RX Stent Study Succeeds Sep 02 2014
    Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG Sep 02 2014
    Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial Aug 30 2014
    Boston Scientific nerve device no help in heart failure study Aug 30 2014
    Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign... Aug 29 2014
    Boston Scientific Wins Second Mesh Trial, Lawyer Says Aug 29 2014
    Frustrating Boston Scientific Is Not What the Investor Ordered Aug 28 2014
    Why St. Jude Medical Has Become a Must-Own Medical Device Stock Aug 26 2014
    Boston Scientific To Participate In 2014 Morgan Stanley Global Healthcare Conference Aug 25 2014
    Boston Scientific-ASAHI INTECC JV to Improve Cardiac Care Aug 21 2014
    Demand for Pacemakers Helps Medtronic Beat Estimates Aug 19 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK